Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safety and Clinical Effectiveness of Induce NMP® in Degenerative Spine Surgery: A Prospective 2-Year Registry

NCT06971835 is registered in ClinicalTrials.gov with Red Rock Regeneration Inc. as lead sponsor.

NCT NCT06971835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06971835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safety and Clinical Effectiveness of Induce NMP® in Degenerative Spine Surgery: A Prospective 2-Year Registry
Lead sponsor
Red Rock Regeneration Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 17, 2026
Completion date
January 31, 2029
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease (ddd), subjects treated with nmp as part of their spine surgery